NR AXBU
AU Roch,J.A.; Hermier,M.; Jouvet,A.; Nighoghossian,N.
TI [Cerebral amyloid angiopathy]
OT L'angiopathie amyloide cerebrale
QU Revue Neurologique 2007 Jan; 163(1): 134-7
PT english abstract; journal article; review
AB Cerebral amyloid angiopathy (CAA) is characterized by deposition of cerebrovascular amyloid protein in the media of leptomeningeal vessels. (amyloid B protein, cystatin C, transthyretin, gelsolin, and prion protein). It is a cause of cerebrovascular disorders including cerebral hemorrhage, cognitive impairment and unusually transient neurological symptoms. It is the main contributing factor to cerebral hemorrhage after hypertension in the elderly. We aimed to review epidemiological, pathophysiological and clinical and MRI imaging data in CAA.
ZR 20
MH *Cerebral Amyloid Angiopathy/diagnosis/physiopathology; Humans
AD Unite Cerebrovasculaire, Pr P Trouillas, Hopital Neurologique et Neurochirurgical Pierre Wertheimer, Bron.
SP französisch
PO Frankreich